Chemesis International Steadily Expanding Key California Footprint
Tony Deyes
March 14th, 2019
Exclusive, News, Top Story, Uncategorized
Chemesis International Inc. (CSE: CSI, OTC: CADMF, FRA: CWAA), the Vancouver-based cannabis first-mover with operations in California, Puerto Rico, and Colombia, knows that dominating the California market, the world’s largest for legal cannabis and a cannabis cultural trend-setter, is an important first step in its strategic plan to expand both nationally and internationally. Recent developments suggest the company is preparing to do exactly that.
California represents over 30% of US legal sales, with 2018 retail sales totalling $2.5 billion. Colorado’s established legal cannabis saw $1.5 billion in retail sales, while Washington saw $1 billion in sales, and Oregon retail sales brought in $600 million.
Innovative Branding
In January Chemesis, in collaboration with filmmaker Kevin Smith, unveiled Jay and Silent Bob’s Private Stash, a genius branding effort based on the iconic stoner-slacker characters famous for their roles in blockbuster films from Clerks to Jay and Silent Bob Strike Back. Smith elaborated on Instagram:
“Back in the day, @jayandsilentbob used to sell weed in the movies. Now, thanks to the good folks at @chemesis.tv, Jay and Silent Bob are selling weed in real life! This January Jay and Silent Bob’s Private Stash debuts in every weed-legal state and every weed-legal store they can lean against! Smoke some Snoogans (an Indica)! Blaze some Berserker (a Sativa)! Or go both ways with Snoochie Boochies (a Hybrid)! The green is spectacular (…) pre-rolls come in collectible containers that fit into Quick Stop Dispensary and THC Video display cases! The #chemesis kids brought me out to the #mjbizcon where we made the announcement and I played with the prototypes! We start with pre-rolls, 5 packs and jars of flower, but next up? Oils and Pet CBD’s! In 2019, say hi to Jay and Silent Bob’s Private Stash! It’s no longer a secret and it’ll bowl you over!”
Click here to stay up-to-date with Chemesis’ corporate developments.
Interviewed by CFN, Chemesis CEO Edgar Montero praised Smith for his big heart and the entire team for its passion for the cannabis industry. Mr. Montero said that, based on an appearance featuring Smith at the Emerald Cup, northern California’s premier annual cannabis industry celebration, the company received over US$100 thousand in purchase orders, so the brand’s potential is proven.
As cannabis legalization gradually rolled out across California, Chemesis kept its finger on the pulse and worked with early adopters of new regulations to establish several key operations in Cathedral City; California Sap, with over 40 awards celebrating the quality of its branded extract-based products, its state-of-the-art extraction facility that can process over 500,000 kgs of cannabis trim annually, and finally Desert Zen, which handles packaging and distribution for Chemesis’ in-house brands as well as offering contract services to other brands. To strengthen its brand presence throughout California, Chemesis has engaged Dank City, a premier cannabis marketing firm boasting the largest network of social media pages related to the industry.
Expanding Capacity to Meet Demand
The growing demand for its branded products and extract services requires additional support, and Chemesis just announced the acquisition of a fully licensed, state of the art extraction & manufacturing facility, also located in Cathedral City, which is expected to double its ability to process large amounts of cannabis to extract THC, CBD, and other cannabinoid and terpene products, to over 500,000 kg annually.
The facility’s proximity to Chemesis’ existing extraction facility, which commenced operations this quarter, is expected to streamline operations and gives Chemesis control of two fully licensed, commercialized facilities, providing the necessary infrastructure for a controlled national expansion. Through the acquisition, Chemesis gains control over two additional Cannabis Business Local licenses and a Type 7 Adult & Medical Cannabis Products manufacturing license.
Click here to stay up-to-date with Chemesis’ corporate developments.
Montero said, “The company will, upon completion of the acquisition, significantly increase its production and manufacturing capabilities in the U.S. The addition of this new facility will allow the company to extract high-quality cannabinoids and terpenes for use in a wide variety of consumer products. Chemesis will then be able to leverage its existing expertise in extraction, distribution, and sales to continue growing revenues and build long-term value. I believe this expansion will open up considerable new revenue opportunities for the company when we begin processing hemp.”
The US is the only industrialized nation with a ban on the production of industrial hemp, but provisions in last year’s federal Farm Bill finally addressed the issue, and Chemesis is currently looking at processing hemp at the new facility for full spectrum extracts rich in CBD to meet growing demand. The CBD market is growing at a much faster rate than any other aspect of the cannabis market, predicted to become a multi-billion-dollar industry by 2020. The hemp-derived CBD market is expected to be especially lucrative, with a 2017 report by Brightfield Group predicting a per annum increase of 55% over the next five years.
Chemesis has proven itself a forward-thinking company with its early-mover position in the key markets of California, Colombia, and Puerto Rico. Wth its expanded capacity and a strong brand presence throughout the state, 2019 should be a pivotal year as Chemesis cements its role as a key player in the highly lucrative California market, providing the resources to pursue its ambitious strategic goals both domestically and internationally.
Click here to stay up-to-date with Chemesis’ corporate developments.
And connect with Chemesis in social media:
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Tony Deyes
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Innovium is a global beverage and foods brands platform that builds on consumer market trends and takes them to scale.
Aleafia, a vertically integrated, national cannabis company, operates major medical clinic, cannabis cultivation and R&D facilities.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
